Myeloma and Plasma Cell Disorders Meeting 2019

Programme

14:00 Welcome - Dr Rakesh Popat (Lecture Theatre C3.09)

Understanding and harnessing immune function

• Chair: Prof Kwee Yong

14:05 Immunomodulatory targets on the clinical horizon - Dr Kyohei Nakamura, Smyth Lab

14:25 How do insights from animal models advance clinical care in myeloma? - Dr Kim De Veirman, Vanderkerken Lab

14:45 CAR T therapy in myeloma: an update - Dr Lydia Lee

Advances and uncertainties in clinical practice

• Chair: Dr Jonathan Sive

15:05 Smouldering myeloma: What should we be doing? - Prof Kwee Yong

15:25 COFFEE BREAK (Room C3.11)

Advances and uncertainties in clinical practice (cont.) Chair: Dr Jonathan Sive

15:50 Novel myeloma treatments and clinical trials at UCLH - Dr Rakesh Popat

16:10 NICE appraisals: How to integrate these into the treatment pathway? - Dr Neil Rabin

Plenary lecture

• Chair: Dr Ashu Wechalekar

16:30 Where do new immunotherapies fit into the myeloma treatment pathway? - Dr Shaji Kumar

Clinical case discussion

• Chair: Dr Neil Rabin

17:30 Presentation of clinical cases - Dr Jonathan Sive and Dr Chara Kyriakou

18:00 Summary and close - Prof Kwee Yong

18:15 onwards: Drinks reception

Parallel Session for Clinical Nurse Specialists and Trial Practitioners

14:05 - 15:05 - Coordinated and run by Aviva Cerner, UCH Myeloma CNS. (Room C3.13)

• Nurse-led clinics
• Best practice Daratumumab infusions
• Management of treatment toxicities

This meeting is approved for 3 CPD credits by the Royal College of Pathologists.